EurekAlert! -
1 Jun 2020 06:00
(University of Liverpool) New research conducted by the University of Liverpool and AKL Research and Development Ltd (AKLRD), published in Inflammopharmacology, highlights the potential benefits of a new drug treatment on the human body's immune response in inflammation.
Share this Article